1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsProvides grants to support development of medical products for rare diseases.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Clinical investigators in the U. S. Confirm the full requirements in the official notice before applying.
Orphan Products Grants Program is funded by FDA. Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
Clinical Studies of Orphan Products Addressing Unmet Needs of Rare Diseases (R01) RFA-FD-25-020 is sponsored by U.S. Food and Drug Administration (FDA) - Office of Orphan Products Development (OOPD). This funding opportunity supports clinical trials of products evaluating efficacy and/or safety for a new indication or change in labeling to address unmet needs in rare diseases or conditions. The goal is to increase the number of approved treatments for rare diseases.
Clinical Studies of Orphan Products Addressing Unmet Needs of Rare Diseases (R01) is sponsored by Food and Drug Administration (FDA). Funds clinical trials for products (drugs, biologics, or devices) that evaluate safety and efficacy for the treatment of rare diseases or conditions affecting fewer than 200,000 people in the US.